Roche Holding AG 3Q 2016 -- Forecast

FRANKFURT--The following is a summary of analysts' forecasts for Roche Holding AG (RO.EB) third-quarter sales results, based on a poll of seven analysts conducted by Dow Jones Newswires (figures in million Swiss francs, dividend and target price in Swiss francs, according to IFRS). Earnings figures are scheduled to be released October 20.

=== 
              Sales: 
                                 -MabTh. 
3rd Quarter     -Total -Pharma /Rituxan -Avastin -Herceptin 
AVERAGE         12,553   9,816    1,844    1,786      1,691 
Prev. Year      11,940   9,340    1,772    1,705      1,614 
+/- in %          +5.1    +5.1     +4.1     +4.8       +4.8 
 
MEDIAN          12,570   9,819    1,841    1,786      1,695 
Maximum         12,654   9,924    1,883    1,830      1,725 
Minimum         12,434   9,697    1,800    1,750      1,642 
Amount               7       7        7        7          7 
 
Baader-Helvea   12,434   9,697    1,800    1,750      1,642 
Cowen & Company 12,575   9,825    1,840    1,830      1,725 
Deutsche Bank   12,601   9,817    1,859    1,786      1,709 
Jefferies       12,536   9,792    1,825    1,777      1,701 
Morgan Stanley  12,502   9,819    1,841    1,781      1,671 
Vontobel        12,570   9,836    1,883    1,788      1,695 
Zuercher KB     12,654   9,924    1,861    1,790      1,695 
 
               Target price  Rating                DPS 2016 
AVERAGE              294.50  positive 7  AVERAGE       8.34 
Prev. Quarter        292.86  neutral  1  Prev. Year    8.10 
+/- in %               +0.6  negative 0  +/- in %      +3.0 
 
MEDIAN               298.00              MEDIAN        8.34 
Maximum              306.00              Maximum       8.50 
Minimum              275.00              Minimum       8.20 
Amount                    6               Amount          4 
 
Baader-Helvea        296.00  Buy                         -- 
Cowen and Company        --  Market perform              -- 
Deutsche Bank        290.00  Buy                       8.33 
Jefferies            275.00  Buy                       8.34 
Morgan Stanley       300.00  Overweight                  -- 
UBS                  300.00  Buy                         -- 
Vontobel             306.00  Buy                       8.50 
Zuercher KB              --  Overweight                8.20 
===

Year-earlier figures are as reported by the company.